- FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre riskCNBC
- FDA flags Guillain-Barré risks for GSK, Pfizer RSV shot, but only one will need safety trialFierceBiotech
- FDA advisors recommend the world’s first RSV vaccine from PfizerNBC News
- US FDA panel votes in favor of Pfizer’s RSV vaccineReuters
- Pfizer’s RSV vaccine wins US panel’s support for safety in older peopleBloomberg
- See the full coverage on Google News
Source link
Read Next
July 25, 2023
Banc of California, PacWest in Advanced Talks to Combine – WSJ – The Wall Street Journal
July 25, 2023
Pan Gongsheng appointed head of China’s central bank
July 25, 2023
3M raises full-year earnings forecast as cost measures pay off
July 25, 2023
Airline shares fall after Alaska Air Group update
July 25, 2023
Amazon cuts iRobot deal price by 15% after Roomba maker incurs new debt
July 25, 2023
The Chevy Bolt EV is back on the market, months after GM scrapped it
July 25, 2023
GM earnings rise | CNN Business
July 25, 2023
Sensing the end of Fed hikes, some investors are returning to dividend stocks
July 25, 2023
GE, GM, 3M, Spotify, Verizon and more stock market movements
July 25, 2023
GM beats revenue estimates with pricing and demand in flux. The stock rises.
